Researchers at University of Utah Health have designed new digital tools that use relevant information from patient health records to prompt doctors to consider lung cancer screening for high-risk patients and provide personalized guidance on screening.
New data highlights two novel proteomic tests that support treatment decision making in patients with non-small cell lung cancer :
Expanded analysis of the VeriStrat® host immune classifier’s.
The American Lung Association reported 41% of Utah homes have dangerous levels of radon gas, the second highest cause of lung cancer. Utahns are encouraged to test their home.